Assessing the protection elicited by virus-like particles expressing the RSV pre-fusion F and tandem repeated G proteins against RSV rA2 line19F infection in mice
Abstract Excessive pulmonary inflammation is the hallmark of respiratory syncytial virus (RSV) infection hindering efficacious RSV vaccine development. Yet, the vast majority of the experimental RSV vaccine studies use laboratory-adapted RSV strains that do not reflect the highly pathogenic and infl...
Main Authors: | Min-Ju Kim, Ki Back Chu, Su-Hwa Lee, Jie Mao, Gi-Deok Eom, Keon-Woong Yoon, Eun-Kyung Moon, Fu-Shi Quan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12931-023-02641-w |
Similar Items
-
Transdermal Immunization with Microparticulate RSV-F Virus-like Particles Elicits Robust Immunity
by: Sucheta D’Sa, et al.
Published: (2022-04-01) -
Two RSV Platforms for G, F, or G+F Proteins VLPs
by: Binh Ha, et al.
Published: (2020-08-01) -
Comparison of Immune Responses to Different Versions of VLP Associated Stabilized RSV Pre-Fusion F Protein
by: Lori M. Cullen, et al.
Published: (2019-02-01) -
The RSV F p27 peptide: current knowledge, important questions
by: Wanderson Rezende, et al.
Published: (2023-06-01) -
RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical Models
by: Freek Cox, et al.
Published: (2023-03-01)